XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity (Tables)
3 Months Ended
Mar. 31, 2017
Equity  
Schedule of equity

Equity activity was as follows (in thousands):

 

 

 

 

 

 

 

Total

 

 

 

Equity

 

Balance at December 31, 2016

    

$

740,048

 

Net income

 

 

21,513

 

Proceeds from common stock issued, net of issuance costs

 

 

14,529

 

Stock-based compensation expense

 

 

1,259

 

Performance based stock units

 

 

(6)

 

Common stock dividends

 

 

(22,552)

 

Other

 

 

(1,651)

 

Balance at March 31, 2017

 

$

753,140

 

 

Schedule of cash dividends declared and paid

We declared and paid the following cash dividends (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

March 31, 2017

 

March 31, 2016

 

 

 

 

Declared

 

Paid

 

Declared

 

Paid

 

 

Common Stock

 

$

22,552

(1)

$

22,552

(1)

$

20,347

(2)

$

20,347

(2)

 


(1)

Represents $0.19 per share per month for the three months ended March 31, 2017.

 

(2)

Represents $0.18 per share per month for the three months ended March 31, 2016.

Schedule of restricted stock granted

 

 

 

 

 

 

 

 

 

 

 

No. of 

 

Price per

 

 

 

Year

 

Shares/Units

 

Share

 

Vesting Period

 

2017

 

74,760

 

$

45.76

 

ratably over 3 years

 

 

 

57,881

 

$

45.76

 

TSR targets (1)

 

 

 

132,641

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016

 

65,300

 

$

43.24

 

ratably over 3 years

 


(1)

Vesting is based on achieving certain total shareholder return (or TSR) targets in 4 years with acceleration opportunity in 3 years.

Schedule of unrecognized compensation

 

 

 

 

 

 

Remaining 

 

 

Compensation

Vesting Date

    

Expense

2017

 

$

3,997,000

2018

 

 

4,147,000

2019

 

 

2,312,000

2020

 

 

251,000

 

 

$

10,707,000